FDA recall record

NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg) recall — FDA D-0395-2021

Subpotent Drug

Class Iclassification
D-0395-2021official record ID
Jun 2, 2021report date

Recall record at a glance

Official recordD-0395-2021
CategoryDrug Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmAcella Pharmaceuticals, LLC
Report dateJun 2, 2021
Recall initiation dateApr 29, 2021
Quantitya) 66,155 bottles; b) 26,212 bottles
LocationAlpharetta, GA, United States

Official product description

NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Why the product was recalled

Subpotent Drug

Distribution information

Nationwide within the United States including Puerto Rico

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Press Release.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugOct 28, 2020

NP THYROID 15 recall — FDA D-0035-2021

Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.

Class IFDA: TerminatedAcella Pharmaceuticals, LLC